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Background
Community involvement and implementation of ethical
standard are vital in HIV vaccine trial. There is a need for
synergy between community involvement and ethics
towards successful trial in Nigeria. This is enhanced
through involving community in planning, implementa-
tion of protocol and dissemination of research findings.
This will give room for communities to understand the
benefit of HIV vaccine, and ensure effective participation
and partnership.
Methods
Questionnaires were administered to 322 participants in
30 communities in Southwestern Nigeria from August
2007–January 2008. The questionnaires assessed aware-
ness about informed consent, previous research participa-
tion, knowledge, willingness and obstacles to
participation.
Results
Median age: 32.8 years (range 18–58); male 148 (46%);
female 174 (54%); rural dwellers (60%) and urban dwell-
ers (40%). Ever participated in HIV research 66%, No
34%; ever signed an informed consent 26%; previous par-
ticipation due to financial inducement 22%; willingness
to participate in future HIV vaccine trial (64%); No (26%)
Don't know (10%); willingness to participate if there is
community involvement 91%, willingness to participate
if encouraged by community leader/partner 94%. Reasons
for refusal to participate: fear 36%, lack of involvement of
community head/leader 22%, previous research without
community benefit 18% and stigma 10%. Factors that
favor participation included: male OR = 1.3, 95% CI 1.2–
1.9 and age ≤ 40 years OR = 1.8, 95% CI 1.4–2.9.
Conclusion
Adequate emphasis should be placed on community
involvement and ethical issues in HIV vaccine trial with
relevance to planning, study design, informed consent
and research accountability. It is important to appreciate
factors that influence community mobilization and
involvement. Researchers and communities need to have
proper understanding of ethical issues. In addition, there
is a need to educate communities of the risks and benefits
with information that is culturally and scientifically
appropriate to promote involvement.
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